3Christiane JB, Matthew TH, Darren WD, et al. Epidermal growth factor receptor blockade with C225 plus gemcitahine results in regression of human pancreatic carcinoma growing orthotopieally in nude mice by antiangiogenic mechanisms[J]. Clin Cancer Res ,2000,6(5) ,, 1 936 - 1 948,
4Inoue kJ, slaton JW, Perrotte P, et al. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma[J]. Clin cancer Res,2000,6:4 874-4 884.
5Huang SM, Book JM, Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck[J]. Cancer Res , 1999,59 (4) : 1 935 - 1 940.
6Ciardiello F, Bianco R, miano V, et al. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225 [J]. Clin Cancer Res, 1999,5(4) :909- 916.
7Aboud-pirak E, Hurwitz E, Pirak ME, et al. Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice[J]. Natl Cancer Inst, 1988,80:1 605-1 611.
8Baselga J, Norton L, Masui H, et al. Antitumore, effect of doxorubicin in combinition with anti-epidermal growth factor receptor monoclonal antibodies [J]. Natl Cancer Inst, 1993, 85:1 327-1 333.
9Fan Z, baselga J, Masui H, et al. Antitumore effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts[J].Cancer Res, 1993,53:4 637 - 4 642.
10Karashima T, Sweeney P, Slaton JW, et al. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen independent prostate[J], Cancer Res ,2002,8(5):1 253 - 1 264.
